Although DDX3X predominantly localizes to the cytoplasm, which is closely related to the efficiency of N-terminal leucine-rich nuclear export signal–dependent (NES-dependent) CRM1-mediated export (8), nuclear DDX3X has been found to predict poor outcomes in colorectal and breast cancers (9). Here, DDX3X is linked to breast cancer.